Ongoing Stability Documentation Gaps in Regulatory Audits

Identifying and Resolving Gaps in Ongoing Stability Programs During Regulatory Audits In the pharmaceutical manufacturing landscape, maintaining compliance with ongoing stability programs is crucial, yet many organizations face challenges that…

How to Handle OOT Results in Bracketing and Matrixing Studies

Addressing Out-of-Trend Results in Bracketing and Matrixing Studies Out-of-Trend (OOT) results in stability studies present significant challenges for pharmaceutical manufacturers. These unexpected outcomes can lead to regulatory scrutiny, product re-evaluations,…

Bracketing Misuse for Different Container Closure Systems

Addressing Misuse of Bracketing in Container Closure Systems Bracketing and matrixing misuse can significantly affect the reliability of stability studies, jeopardizing regulatory compliance and impacting product lifecycle management. This article…

How to Write SOPs for Ongoing Stability Study Management

Managing Gaps in Ongoing Stability Programs in Pharmaceutical Manufacturing The management of ongoing stability programs is critical in ensuring regulatory compliance and product integrity within pharmaceutical manufacturing. Despite efforts to…